Moneycontrol Be a Pro
Get App
Last Updated : Feb 07, 2019 03:25 PM IST | Source: PTI

Lupin gets USFDA nod for generic version of Tadalafil tablets

The company has received approval from the US Food and Drug Administration to market a generic version of Eli Lilly and Company's Adcirca tablets in 20 mg strength.


Drug firm Lupin on February 7 said it has received approval from the US health regulator to market a generic version of Tadalafil tablets, used to treat pulmonary arterial hypertension.

The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Eli Lilly and Company's Adcirca tablets in 20 mg strength, Lupin said in a statement.

It is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability.

Close

As per IQVIA MAT December 2018 data, Lupin said, the Tadalafil tablets, 20 mg had annual sales of around USD 474.3 million in the US.

Lupin shares were trading 2.42 percent down at Rs 821.85 apiece on the BSE.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Feb 7, 2019 03:14 pm
Loading...
Sections
Follow us on
Available On